Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10030 |
| Vaccine Name | Covovax (Nuvaxovid) |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Protein subunit |
| Vaccine Status | Approved |
| Manufacturer | Novavax Inc. |
| Year of Manufacturing | NA |
| Manufacturing Country | UK |
| Age | NA |
| Dosage | 2 doses |
| Administration Route | Intramuscular |
| Adjuvant | Matrix-M |
| Target Strain | Spike protein of SARS-CoV-2 virus |
| Description | NA |
| Approving Organisation | US FDA |
| Collaborating Organisation | NA |
| Other Countries | USA, Mexico |
| Trade Name | TAK-019, SARS-CoV-2 rS, NVX-CoV2373 |
| PMID | 32328406 |
| Clinical Trial ID | NA |
| Reference Link | https://pubmed.ncbi.nlm.nih.gov/32328406/ |
| Additional Links | https://clinicaltrials.gov/ct2/show/NCT05249816 |